About
Biocon - BIOCON
Biocon, founded in 1978, is a leading biopharmaceutical company headquartered in India, operating primarily in the biotechnology sector. The company focuses on developing innovative medicines across various segments, including diabetes care, oncology, and immunology. Biocon offers a wide range of products, such as insulin formulations, monoclonal antibodies, and biosimilars, which are known for their quality and affordability, giving them a competitive edge. With a strong domestic presence and expanding international reach, Biocon plays a crucial role in making healthcare accessible globally, leveraging cutting-edge technology and research to improve patient outcomes and address unmet medical needs.